ArticleTranslational cancer research2024

CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells.

Sung Hee Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.